Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-κB ligand by osteoblasts
- 25 October 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 298 (2) , 240-246
- https://doi.org/10.1016/s0006-291x(02)02440-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Osteoblast Maturation Suppressed Osteoclastogenesis in Coculture with Bone Marrow CellsBiochemical and Biophysical Research Communications, 2000
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997
- Regulation of Osteoclast FunctionJournal of Bone and Mineral Research, 1997
- Cimetidine-Induced Myelosuppression After Bone Marrow TransplantationLeukemia & Lymphoma, 1994
- Partial inhibition of bone resorption by disodium cromoglycata in a synchronized model of bone remodelingInflammation Research, 1991
- Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors.The Journal of Experimental Medicine, 1991
- Changes in mast cell number during the activation phase of an induced synchronized remodeling sequence in the ratBone, 1990
- Histamine regulates the generation of human cytolytic T lymphocytesCellular Immunology, 1989
- The influence of histamine on precursors of granulocytic leukocytes in murine bone marrowLife Sciences, 1988